Dr. Carl C. Capelouto graduated Phi Beta Kappa and magna cum laude from the University of Florida. He graduated magna cum laude and Alpha Omega Alpha from Emory University School of Medicine. He then completed his internship at Brigham and Women's Hospital, Harvard Medical School, and completed his residency in the Harvard program of Urology.
Dr. Capelouto's areas of expertise include minimally invasive treatments of many urological conditions. He is a leader in the treatment of enlarged prostate/benign prostatic hyperplasia (BPH), with a special focus on the innovative and minimally invasive UroLift System, Rezum, and Aquablation Therapy procedures.